263 related articles for article (PubMed ID: 25823664)
1. Ndrg2 promoter hypermethylation triggered by helicobacter pylori infection correlates with poor patients survival in human gastric carcinoma.
Ling ZQ; Ge MH; Lu XX; Han J; Wu YC; Liu X; Zhu X; Hong LL
Oncotarget; 2015 Apr; 6(10):8210-25. PubMed ID: 25823664
[TBL] [Abstract][Full Text] [Related]
2. Helicobacter pylori infection promotes methylation of WWOX gene in human gastric cancer.
Yan J; Zhang M; Zhang J; Chen X; Zhang X
Biochem Biophys Res Commun; 2011 Apr; 408(1):99-102. PubMed ID: 21466786
[TBL] [Abstract][Full Text] [Related]
3. Loss of TFF1 promotes Helicobacter pylori-induced β-catenin activation and gastric tumorigenesis.
Soutto M; Romero-Gallo J; Krishna U; Piazuelo MB; Washington MK; Belkhiri A; Peek RM; El-Rifai W
Oncotarget; 2015 Jul; 6(20):17911-22. PubMed ID: 25980439
[TBL] [Abstract][Full Text] [Related]
4. Stepwise cumulation of RUNX3 methylation mediated by Helicobacter pylori infection contributes to gastric carcinoma progression.
Lu XX; Yu JL; Ying LS; Han J; Wang S; Yu QM; Wang XB; Fang XH; Ling ZQ
Cancer; 2012 Nov; 118(22):5507-17. PubMed ID: 22576578
[TBL] [Abstract][Full Text] [Related]
5. Helicobacter pylori causes epigenetic dysregulation of FOXD3 to promote gastric carcinogenesis.
Cheng AS; Li MS; Kang W; Cheng VY; Chou JL; Lau SS; Go MY; Lee CC; Ling TK; Ng EK; Yu J; Huang TH; To KF; Chan MW; Sung JJ; Chan FK
Gastroenterology; 2013 Jan; 144(1):122-133.e9. PubMed ID: 23058321
[TBL] [Abstract][Full Text] [Related]
6. Helicobacter pylori CagA induces tumor suppressor gene hypermethylation by upregulating DNMT1 via AKT-NFκB pathway in gastric cancer development.
Zhang BG; Hu L; Zang MD; Wang HX; Zhao W; Li JF; Su LP; Shao Z; Zhao X; Zhu ZG; Yan M; Liu B
Oncotarget; 2016 Mar; 7(9):9788-800. PubMed ID: 26848521
[TBL] [Abstract][Full Text] [Related]
7. Proteomics-Based Identification and Analysis of Proteins Associated with Helicobacter pylori in Gastric Cancer.
Zhou J; Wang W; Xie Y; Zhao Y; Chen X; Xu W; Wang Y; Guan Z
PLoS One; 2016; 11(1):e0146521. PubMed ID: 26745502
[TBL] [Abstract][Full Text] [Related]
8. H. pylori modifies methylation of global genomic DNA and the gastrin gene promoter in gastric mucosal cells and gastric cancer cells.
Xie Y; Zhou JJ; Zhao Y; Zhang T; Mei LZ
Microb Pathog; 2017 Jul; 108():129-136. PubMed ID: 28478202
[TBL] [Abstract][Full Text] [Related]
9. Helicobacter pylori induces promoter hypermethylation and downregulates gene expression of IRX1 transcription factor on human gastric mucosa.
Guo XB; Guo L; Zhi QM; Ji J; Jiang JL; Zhang RJ; Zhang JN; Zhang J; Chen XH; Cai Q; Li JF; Yan M; Gu QL; Liu BY; Zhu ZG; Yu YY
J Gastroenterol Hepatol; 2011 Nov; 26(11):1685-90. PubMed ID: 21649733
[TBL] [Abstract][Full Text] [Related]
10. Mir-30d increases intracellular survival of Helicobacter pylori through inhibition of autophagy pathway.
Yang XJ; Si RH; Liang YH; Ma BQ; Jiang ZB; Wang B; Gao P
World J Gastroenterol; 2016 Apr; 22(15):3978-91. PubMed ID: 27099441
[TBL] [Abstract][Full Text] [Related]
11. [Association between the expression and methylation of energy-related genes with Helicobacter pylori infection in gastric cancer].
Xu WJ; Zhou JJ; Xie Y; Wang WL; Zhao Y; Chen X; Li Y
Zhonghua Yi Xue Za Zhi; 2012 Feb; 92(6):366-70. PubMed ID: 22490893
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation of NDRG2 in gastric cancer and its clinical significance.
Chang X; Li Z; Ma J; Deng P; Zhang S; Zhi Y; Chen J; Dai D
Dig Dis Sci; 2013 Mar; 58(3):715-23. PubMed ID: 23010743
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of tumor suppressor RACK1 by Helicobacter pylori infection promotes gastric carcinogenesis through the integrin β-1/NF-κB signaling pathway.
Hu Y; Liu JP; Li XY; Cai Y; He C; Li NS; Xie C; Xiong ZJ; Ge ZM; Lu NH; Zhu Y
Cancer Lett; 2019 May; 450():144-154. PubMed ID: 30849478
[TBL] [Abstract][Full Text] [Related]
14. Relationship between LINE-1 hypomethylation and Helicobacter pylori infection in gastric mucosae.
Kosumi K; Baba Y; Ishimoto T; Harada K; Miyake K; Izumi D; Tokunaga R; Murata A; Eto K; Sugihara H; Shigaki H; Iwagami S; Sakamoto Y; Miyamoto Y; Yoshida N; Watanabe M; Komohara Y; Takeya M; Baba H
Med Oncol; 2015 Apr; 32(4):117. PubMed ID: 25782871
[TBL] [Abstract][Full Text] [Related]
15. NDRG2, suppressed expression associates with poor prognosis in pancreatic cancer, is hypermethylated in the second promoter in human gastrointestinal cancers.
Yamamura A; Miura K; Karasawa H; Motoi F; Mizuguchi Y; Saiki Y; Fukushige S; Sunamura M; Shibata C; Unno M; Horii A
Biochem Biophys Res Commun; 2017 Feb; 484(1):138-143. PubMed ID: 28093228
[TBL] [Abstract][Full Text] [Related]
16. Helicobacter pylori induces promoter methylation of E-cadherin via interleukin-1β activation of nitric oxide production in gastric cancer cells.
Huang FY; Chan AO; Rashid A; Wong DK; Cho CH; Yuen MF
Cancer; 2012 Oct; 118(20):4969-80. PubMed ID: 22415887
[TBL] [Abstract][Full Text] [Related]
17. Promoter methylation regulates Helicobacter pylori-stimulated cyclooxygenase-2 expression in gastric epithelial cells.
Akhtar M; Cheng Y; Magno RM; Ashktorab H; Smoot DT; Meltzer SJ; Wilson KT
Cancer Res; 2001 Mar; 61(6):2399-403. PubMed ID: 11289104
[TBL] [Abstract][Full Text] [Related]
18. Genome-wide DNA methylation profiles in noncancerous gastric mucosae with regard to Helicobacter pylori infection and the presence of gastric cancer.
Shin CM; Kim N; Jung Y; Park JH; Kang GH; Park WY; Kim JS; Jung HC; Song IS
Helicobacter; 2011 Jun; 16(3):179-88. PubMed ID: 21585603
[TBL] [Abstract][Full Text] [Related]
19. Suppressed expression of NDRG2 correlates with poor prognosis in pancreatic cancer.
Yamamura A; Miura K; Karasawa H; Morishita K; Abe K; Mizuguchi Y; Saiki Y; Fukushige S; Kaneko N; Sase T; Nagase H; Sunamura M; Motoi F; Egawa S; Shibata C; Unno M; Sasaki I; Horii A
Biochem Biophys Res Commun; 2013 Nov; 441(1):102-7. PubMed ID: 24134849
[TBL] [Abstract][Full Text] [Related]
20. Genome-wide DNA methylation profiles altered by Helicobacter pylori in gastric mucosa and blood leukocyte DNA.
Zhang Y; Zhang XR; Park JL; Kim JH; Zhang L; Ma JL; Liu WD; Deng DJ; You WC; Kim YS; Pan KF
Oncotarget; 2016 Jun; 7(24):37132-37144. PubMed ID: 27206798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]